panel discussion orally inhaled and nasal drug products (38of39) complex generics 2018
Published 4 years ago • 305 plays • Length 22:00Download video MP4
Download video MP3
Similar videos
-
42:06
final panel discussion – all topics (39of39) complex generics 2018
-
16:27
guidances and faq for orally inhaled and nasal drug products (32of39) complex generics 2018
-
19:35
questions and panel discussion (9of39) complex generics 2018
-
25:59
questions and panel discussion (16of39) complex generics 2018
-
14:24
panel discussion (31of39) complex generics 2018
-
24:52
questions and panel discussion (5of39) complex generics 2018
-
18:37
questions and panel discussion (20of39) complex generics 2018
-
24:45
panel discussion
-
17:27
pre-anda review: office of pharmaceutical quality (opq) (4of39) complex generics 2018
-
20:27
quality considerations for generic orally inhaled drug products (35of39) complex generics 2018
-
18:50
common be deficiencies for orally inhaled drug products in andas (34of39) complex generics 2018
-
11:53
cfd modeling for product development of generic oindps and be (37of39) complex generics 2018
-
30:18
panel discussion
-
30:56
panel discussion
-
19:11
panel discussion
-
13:04
common be deficiencies for orally inhaled drug products in andas (33of39) complex generics 2018
-
14:43
panel discussion
-
31:18
pre-anda logistics and best practices (27of39) complex generics 2018
-
20:57
common issues in complex drug substance review (8of39) complex generics 2018